APA

Tucci M., Mosca A., Lamanna G., Porpiglia F., Terzolo M., Vana F., Cracco C., Russo L., Gorzegno G., Tampellini M., Torta M., Reimondo G., Poggio M., Scarpa R. M., Angeli A., Dogliotti L. & Berruti A. (20090430). Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. : Prostate cancer and prostatic diseases.

Chicago

Tucci M, Mosca A, Lamanna G, Porpiglia F, Terzolo M, Vana F, Cracco C, Russo L, Gorzegno G, Tampellini M, Torta M, Reimondo G, Poggio M, Scarpa R M, Angeli A, Dogliotti L and Berruti A. 20090430. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. : Prostate cancer and prostatic diseases.

Harvard

Tucci M., Mosca A., Lamanna G., Porpiglia F., Terzolo M., Vana F., Cracco C., Russo L., Gorzegno G., Tampellini M., Torta M., Reimondo G., Poggio M., Scarpa R. M., Angeli A., Dogliotti L. and Berruti A. (20090430). Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. : Prostate cancer and prostatic diseases.

MLA

Tucci M, Mosca A, Lamanna G, Porpiglia F, Terzolo M, Vana F, Cracco C, Russo L, Gorzegno G, Tampellini M, Torta M, Reimondo G, Poggio M, Scarpa R M, Angeli A, Dogliotti L and Berruti A. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. : Prostate cancer and prostatic diseases. 20090430.